Publications by authors named "Pierre Michetti"

Claim this Profile
[
[Not Available].
Pierre Michetti

Rev Med Suisse· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey of dietary beliefs and habits of inflammatory bowel disease patients.
Melody Verdina, Frank Seibold, Gaël Grandmaison, Pierre Michetti, Anne-Catherine Barras-Moret

Clin Nutr ESPEN· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Clémentine Fitaire, Pierre Michetti

Rev Med Suisse· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.
Maude Martinho-Grueber, Ioannis Kapoglou, Francisco Bravo, Riad Sarraj, Eileen Benz, Pierre Michetti

Eur J Gastroenterol Hepatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response.
Valerie Heron, Steven Li Fraine, Nicola Panaccione, Sophie Restellini, Pascale Germain, Pierre Michetti

J Can Assoc Gastroenterol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positioning biologics in the treatment of IBD: A practical guide
Pascal Juillerat, Maude Martinho Grueber, Roseline Ruetsch, Giulia Santi, Marianne Vuillèmoz, Pierre Michetti

Curr Res Pharmacol Drug Discov· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease.
Laure F Pittet, Charlotte M Verolet, Pierre Michetti, Elsa Gaillard, Marc Girardin

Digestion· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Algorithms for Crohn's Disease.
Michael Christian Sulz, Emanuel Burri, Pierre Michetti, Gerhard Rogler, Laurent Peyrin-Biroulet

Digestion· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An Update.
Marianne Vulliemoz, Stephan Brand, Pascal Juillerat, Christian Mottet, Shomron Ben-Horin, Pierre Michetti

Digestion· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus.
Thomas Greuter, Michel H Maillard, Pascal Juillerat, Pierre Michetti, Frank Seibold

Digestion· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
Orla Mader, Pascal Juillerat, Luc Biedermann, Pierre Michetti, Petr Hruz

United European Gastroenterol J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know.
Philipp Schreiner, Nicolas J Mueller, Jan Fehr, Michel H Maillard, Stephan Brand, Pierre Michetti

J Crohns Colitis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Recommendations and Quality of Endoscopic Colorectal Cancer Surveillance in Long-Standing Ulcerative Colitis.
Giulia Santi, Pierre Michetti, Florian Froehlich, Jean-Benoît Rossel, Valérie Pittet

Inflamm Intest Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Pierre Michetti

Rev Med Suisse· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Position statement on the use of biosimilars in inflammatory bowel disease.
Emanuel Burri, Pascal Juillerat, Michel H Maillard, Michael Manz, Pierre Michetti

Swiss Med Wkly· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
Valérie E H Pittet, Michel H Maillard, Thomas Simonson, Nicolas Fournier, Gerhard Rogler, Pierre Michetti

Clin Gastroenterol Hepatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease.
Laure F Pittet, Charlotte M Verolet, Pierre Michetti, Marc Girardin, Pascal Juillerat

Am J Gastroenterol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).
Valérie Pittet, Pierre Michetti, Christoph Mueller, Christian P Braegger, Roland von Känel

Int J Epidemiol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease.
Bahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, Charlotte Ramon, Francisco Damian Bravo, Pierre Michetti

Nat Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab in Refractory Microscopic Colitis: An International Case Series.
Pauline Rivière, Andreas Münch, Pierre Michetti, Nilesh Chande, Gert de Hertogh

J Crohns Colitis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbial network disturbances in relapsing refractory Crohn's disease.
Bahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, Charlotte Ramon, Francisco Damian Bravo, Pierre Michetti

Nat Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported healthcare expectations in inflammatory bowel diseases.
Valérie Pittet, Carla Vaucher, Florian Froehlich, Michel H Maillard, Pierre Michetti

PLoS One· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
Sébastien Godat, Nicolas Fournier, Ekaterina Safroneeva, Pascal Juillerat, Andreas Nydegger, Pierre Michetti

Eur J Gastroenterol Hepatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS).
Ekaterina Safroneeva, Catherine Saner, Jean-Benoît Rossel, Delphine Golay, Valérie Pittet, Pierre Michetti

Inflamm Intest Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of infliximab biosimilars in patients with Crohn's disease.
Pierre Michetti

Lancet· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis